Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients With Chronic Heart Failure and Iron Deficiency.
暂无分享,去创建一个
G. Kemp | A. Shah | G. Charles-Edwards | S. Ayis | T. McDonagh | A. Sleigh | M. Monaghan | N. Catibog | D. Okonko | N. Amaral | G. Amin-Youssef | George F Amin-Youssef
[1] M. Wolf,et al. Randomized trial of intravenous iron-induced hypophosphatemia. , 2018, JCI insight.
[2] J. Kautzner,et al. Skeletal Muscle Abnormalities and Iron Deficiency in Chronic Heart Failure: An Exercise 31P Magnetic Resonance Spectroscopy Study of Calf Muscle , 2018, Circulation. Heart failure.
[3] I. Anand,et al. Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies , 2018, Circulation.
[4] N. Marx,et al. High-Dose Ferric Carboxymaltose in Patients With HFrEF Induces Significant Hypophosphatemia. , 2018, Journal of the American College of Cardiology.
[5] R. Arena,et al. focused update : clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations , 2016 .
[6] David F Wilson. Oxidative phosphorylation: regulation and role in cellular and tissue metabolism , 2017, The Journal of physiology.
[7] S. Russell,et al. Fatigability, Exercise Intolerance, and Abnormal Skeletal Muscle Energetics in Heart Failure , 2017, Circulation. Heart failure.
[8] J. Kautzner,et al. Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis , 2017, European journal of heart failure.
[9] K. Petersen,et al. Hypophosphatemia promotes lower rates of muscle ATP synthesis , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] D. Dunger,et al. Simple and effective exercise design for assessing in vivo mitochondrial function in clinical applications using 31P magnetic resonance spectroscopy , 2016, Scientific Reports.
[11] N. Andrews,et al. Lethal Cardiomyopathy in Mice Lacking Transferrin Receptor in the Heart. , 2015, Cell reports.
[12] N. Andrews,et al. Metabolic Catastrophe in Mice Lacking Transferrin Receptor in Muscle , 2015, EBioMedicine.
[13] C. Barclay,et al. Energetics of contraction. , 2015, Comprehensive Physiology.
[14] G J Kemp,et al. Quantification of skeletal muscle mitochondrial function by 31P magnetic resonance spectroscopy techniques: a quantitative review , 2015, Acta physiologica.
[15] G. Kemp,et al. Skeletal muscle ATP turnover by 31P magnetic resonance spectroscopy during moderate and heavy bilateral knee extension , 2014, The Journal of physiology.
[16] K. Hollingsworth,et al. Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. , 2013, The Journal of clinical endocrinology and metabolism.
[17] S. Carr,et al. Complementary RNA and protein profiling identifies iron as a key regulator of mitochondrial biogenesis. , 2013, Cell reports.
[18] Ian R. Lanza,et al. Measurement of human skeletal muscle oxidative capacity by 31P‐MR spectroscopy: A cross‐validation with in vitro measurements , 2011, Journal of magnetic resonance imaging : JMRI.
[19] P. Poole‐Wilson,et al. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. , 2011, Journal of the American College of Cardiology.
[20] P. Ponikowski,et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. , 2009, The New England journal of medicine.
[21] Willem van Mechelen,et al. Myoglobin concentration in skeletal muscle fibers of chronic heart failure patients. , 2009, Journal of applied physiology.
[22] S. Forbes,et al. Short-term high-intensity interval training improves phosphocreatine recovery kinetics following moderate-intensity exercise in humans. , 2008, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.
[23] S. Eaton,et al. Impact of mutations on the midpoint potential of the [4Fe-4S]+1,+2 cluster and on catalytic activity in electron transfer flavoprotein-ubiquinone oxidoreductase (ETF-QO). , 2008, Biochemistry.
[24] P. Ponikowski,et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. , 2007, Journal of the American College of Cardiology.
[25] D. Graveron-Demilly,et al. Java-based graphical user interface for the MRUI quantitation package , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.
[26] K. Clarke,et al. Metabolic Modulation With Perhexiline in Chronic Heart Failure: A Randomized, Controlled Trial of Short-Term Use of a Novel Treatment , 2005, Circulation.
[27] Ian R. Lanza,et al. Age-related changes in ATP-producing pathways in human skeletal muscle in vivo. , 2005, Journal of applied physiology.
[28] M. D'urso,et al. Functional analysis of TMLH variants and definition of domains required for catalytic activity and mitochondrial targeting , 2005, Journal of cellular physiology.
[29] M. Emond,et al. Extension of Murine Life Span by Overexpression of Catalase Targeted to Mitochondria , 2005, Science.
[30] Vanhamme,et al. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.
[31] G. Radda,et al. Proton efflux in human skeletal muscle during recovery from exercise , 1997, European Journal of Applied Physiology and Occupational Physiology.
[32] G. Kemp. Interactions of mitochondrial ATP synthesis and the creatine kinase equilibrium in skeletal muscle. , 1994, Journal of theoretical biology.
[33] D. Mancini,et al. In Vivo Magnetic Resonance Spectroscopy Measurement of Deoxymyoglobin During Exercise in Patients With Heart Failure: Demonstration of Abnormal Muscle Metabolism Despite Adequate Oxygenation , 1994, Circulation.
[34] G. Radda,et al. Comparisons of ATP turnover in human muscle during ischemic and aerobic exercise using 31P magnetic resonance spectroscopy , 1994, Magnetic resonance in medicine.
[35] H. Beinert,et al. Aconitase, a two‐faced protein: enzyme and iron regulatory factor 1 2 , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] J. Leigh,et al. Relationships between in vivo and in vitro measurements of metabolism in young and old human calf muscles. , 1993, Journal of applied physiology.
[37] G. Radda,et al. Physical training improves skeletal muscle metabolism in patients with chronic heart failure. , 1993, Journal of the American College of Cardiology.
[38] G K Radda,et al. Control of phosphocreatine resynthesis during recovery from exercise in human skeletal muscle , 1993, NMR in biomedicine.
[39] G. Brooks,et al. Iron deficiency: improved exercise performance within 15 hours of iron treatment in rats. , 1990, The Journal of nutrition.
[40] S. Frostick,et al. Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. , 1987, Circulation.
[41] G. Brooks,et al. Distinguishing effects of anemia and muscle iron deficiency on exercise bioenergetics in the rat. , 1984, The American journal of physiology.
[42] J. Wu,et al. Biochemical and EPR probes for structure-function studies of iron sulfur centers of succinate dehydrogenase. , 1976, Advances in experimental medicine and biology.
[43] R. B. Moon,et al. Determination of intracellular pH by 31P magnetic resonance. , 1973, The Journal of biological chemistry.
[44] Ganzoni Am,et al. [Intravenous iron-dextran: therapeutic and experimental possibilities]. , 1970, Schweizerische medizinische Wochenschrift.
[45] A. Ganzoni. [Intravenous iron-dextran: therapeutic and experimental possibilities]. , 1970, Schweizerische medizinische Wochenschrift.
[46] R Hume,et al. Prediction of lean body mass from height and weight , 1966, Journal of clinical pathology.
[47] J. E. O'hagan. The Iron–Protein Link in Hæmoglobin and Myoglobin , 1959, Nature.